Cargando…

CHTOP in Chemoresistant Epithelial Ovarian Cancer: A Novel and Potential Therapeutic Target

Objective: Chemoresistance is a major challenge in epithelial ovarian cancer (EOC) treatment. Chromatin target of protein arginine methyltransferase (CHTOP) was identified as a potential biomarker in chemoresistant EOC cell lines using label-free LC-MS/MS quantitative proteomics. Thus, the aim of th...

Descripción completa

Detalles Bibliográficos
Autores principales:	Feng, Xiaojie, Bai, Xupeng, Ni, Jie, Wasinger, Valerie C., Beretov, Julia, Zhu, Ying, Graham, Peter, Li, Yong
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2019
Materias:	Oncology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6660285/ https://www.ncbi.nlm.nih.gov/pubmed/31380263 http://dx.doi.org/10.3389/fonc.2019.00557

Ejemplares similares

Inhibition of PI3K/Akt/mTOR signaling pathway alleviates ovarian cancer chemoresistance through reversing epithelial-mesenchymal transition and decreasing cancer stem cell marker expression
por: Deng, Junli, et al.
Publicado: (2019)

Activation of the eIF2α/ATF4 axis drives triple-negative breast cancer radioresistance by promoting glutathione biosynthesis
por: Bai, Xupeng, et al.
Publicado: (2021)

Chromatin target of protein arginine methyltransferase regulates invasion, chemoresistance, and stemness in epithelial ovarian cancer
por: Feng, Xiaojie, et al.
Publicado: (2019)

Recent advances of small extracellular vesicle biomarkers in breast cancer diagnosis and prognosis
por: Lee, Yujin, et al.
Publicado: (2023)

Targeting epithelial-mesenchymal transition and cancer stem cells for chemoresistant ovarian cancer
por: Deng, Junli, et al.
Publicado: (2016)

A Standardized and Reproducible Urine Preparation Protocol for Cancer Biomarkers Discovery
por: Beretov, Julia, et al.
Publicado: (2014)

Associations of novel serum lipid index with epithelial ovarian cancer chemoresistance and prognosis
por: Li, Yuan, et al.
Publicado: (2023)

THOC2 and THOC5 Regulate Stemness and Radioresistance in Triple‐Negative Breast Cancer
por: Bai, Xupeng, et al.
Publicado: (2021)

CAF-Associated Paracrine Signaling Worsens Outcome and Potentially Contributes to Chemoresistance in Epithelial Ovarian Cancer
por: Wessolly, Michael, et al.
Publicado: (2022)

Interstitial brachytherapy combined with PARP inhibitors in the treatment of chemoresistant recurrent epithelial ovarian cancer: A case report
por: Bian, Yuan, et al.
Publicado: (2022)

Proteomic Analysis of Urine to Identify Breast Cancer Biomarker Candidates Using a Label-Free LC-MS/MS Approach
por: Beretov, Julia, et al.
Publicado: (2015)

Identification of protein biomarkers and signaling pathways associated with prostate cancer radioresistance using label-free LC-MS/MS proteomic approach
por: Chang, Lei, et al.
Publicado: (2017)

Interactions between KSHV ORF57 and the novel human TREX proteins, CHTOP and CIP29
por: Schumann, Sophie, et al.
Publicado: (2016)

Role of EZH2 in Epithelial Ovarian Cancer: From Biological Insights to Therapeutic Target
por: Li, Hua, et al.
Publicado: (2013)

Proteomic identification of the lactate dehydrogenase A in a radioresistant prostate cancer xenograft mouse model for improving radiotherapy
por: Hao, Jingli, et al.
Publicado: (2016)

Long noncoding RNAs as therapeutic targets to overcome chemoresistance in ovarian cancer
por: Chen, Linjiao, et al.
Publicado: (2022)

Ascitic Senescent T Cells Are Linked to Chemoresistance in Patients With Advanced High-Grade Serous Ovarian Cancer
por: Zhang, Jie, et al.
Publicado: (2022)

Epithelial cell adhesion molecule (EpCAM) is involved in prostate cancer chemotherapy/radiotherapy response in vivo
por: Ni, Jie, et al.
Publicado: (2018)

Emerging Therapeutics to Overcome Chemoresistance in Epithelial Ovarian Cancer: A Mini-Review
por: Cornelison, Robert, et al.
Publicado: (2017)

MSLN Correlates With Immune Infiltration and Chemoresistance as a Prognostic Biomarker in Ovarian Cancer
por: Li, Yike, et al.
Publicado: (2022)

Type I and II PRMTs inversely regulate post-transcriptional intron detention through Sm and CHTOP methylation
por: Maron, Maxim I, et al.
Publicado: (2022)

Potassium channels: Novel targets for tumor diagnosis and chemoresistance
por: Li, Meizeng, et al.
Publicado: (2023)

Circulating unmethylated CHTOP and INS DNA fragments provide evidence of possible islet cell death in youth with obesity and diabetes
por: Syed, Farooq, et al.
Publicado: (2020)

Postoperative Adjuvant Chemotherapy Improved the Prognosis in Locally Advanced Cervical Cancer Patients With Optimal Response to Neoadjuvant Chemotherapy
por: Feng, Xiaojie, et al.
Publicado: (2020)

Hedgehog−Gli2 Signaling Promotes Chemoresistance in Ovarian Cancer Cells by Regulating MDR1
por: Wang, Qian, et al.
Publicado: (2022)

The Role and Therapeutic Perspectives of Sirtuin 3 in Cancer Metabolism Reprogramming, Metastasis, and Chemoresistance
por: Zhao, QingYi, et al.
Publicado: (2022)

Chemoresistance is associated with Beclin-1 and PTEN expression in epithelial ovarian cancers
por: YING, HUANCHUN, et al.
Publicado: (2015)

Leptin contributes to the taxol chemoresistance in epithelial ovarian cancer
por: Gu, Fei, et al.
Publicado: (2019)

Novel Ex Vivo Models of Epithelial Ovarian Cancer: The Future of Biomarker and Therapeutic Research
por: Clark, James, et al.
Publicado: (2022)

The Mechanism of Warburg Effect-Induced Chemoresistance in Cancer
por: Liu, Chang, et al.
Publicado: (2021)

Novel and Alternative Targets Against Breast Cancer Stemness to Combat Chemoresistance
por: Sridharan, Sangita, et al.
Publicado: (2019)

Targeting chemoresistance and mitochondria-dependent metabolic reprogramming in acute myeloid leukemia
por: Feng, Lili, et al.
Publicado: (2023)

Identification of LSM family members as potential chemoresistance predictive and therapeutic biomarkers for gastric cancer
por: Liu, Qianhui, et al.
Publicado: (2023)

Ovarian type epithelial tumor of the tunica vaginalis with abdominal metastasis
por: Smith, Hugh, et al.
Publicado: (2018)

Chtop (Chromatin target of Prmt1) auto-regulates its expression level via intron retention and nonsense-mediated decay of its own mRNA
por: Izumikawa, Keiichi, et al.
Publicado: (2016)

Histones and Their Modifications in Ovarian Cancer – Drivers of Disease and Therapeutic Targets
por: Marsh, Deborah J., et al.
Publicado: (2014)

Lin28A/CENPE Promoting the Proliferation and Chemoresistance of Acute Myeloid Leukemia
por: Shi, Mingyue, et al.
Publicado: (2021)

Stemness and chemoresistance in epithelial ovarian carcinoma cells under shear stress
por: Ip, Carman K. M., et al.
Publicado: (2016)

Can Stemness and Chemoresistance Be Therapeutically Targeted via Signaling Pathways in Ovarian Cancer?
por: Roy, Lynn, et al.
Publicado: (2018)

Epigenetic Mechanisms and Therapeutic Targets in Chemoresistant High-Grade Serous Ovarian Cancer
por: Matthews, Bayley G., et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_cp70frte1rpeiqa0hs5mljfted